At a glance
ClinicalIndex Comparison RecordN/ACompleted· 12 enrolled
Drug / intervention
RD SET Neo SpO2device
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Feasibility and Performance Evaluation of INVSENSOR00024
In Brief
A clinical study evaluating RD SET Neo SpO2 for Evaluation of SpO2 Performance. Completed, enrolled 12 participants across 1 site.
Detailed Summary
This is a prospective, non-randomized, single arm study design to evaluate SpO2 performance of the INVSENSOR00024 sensors in the neonatal population in a clinical environment using convenience sampling.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsEvaluation of SpO2 Performance
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20192020202120222023202420252026
First PostedFeb 2019
Enrollment StartFeb 2019
Primary CompletionMay 2019
TodayJul 2026
First PostedFeb 5, 2019
Enrollment StartFeb 8, 2019
Primary CompletionMay 28, 2019
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 7.4 years ago
Interventions
RD SET Neo SpO2device
All subjects are enrolled in the experimental group and receive the RD SET Neo SpO2 sensor.